The U.S. government, in response to the COVID-19 outbreak, seeks information from stakeholders on available medical countermeasures in development. We are particularly interested in products and technologies that have progressed into or beyond non-clinical trials, have established large-scale cGMP manufacturing capability, or utilize an approved platform. Information regarding diagnostics, therapeutics, vaccines, and other products or technologies relevant to addressing this outbreak are sought…
Ideal technologies and products would (but are not required to) be:
- Relevant to the U.S. government COVID-19 medical countermeasure research and development efforts and/or Emerging Infectious Disease rapid response capabilities
- Utilize an already-approved platform, have non-clinical data suggesting efficacy, and/or have significant manufacturing capability
- Fully owned or licensed by your organization (you have full IP rights and/or freedom to operate)
Would you like to meet with a federal agency regarding a product that you are developing for COVID-19?
Source: Coronavirus portal. Medical Countermeasures.gov.
